Login to Your Account

Regulatory NEWS

HONG KONG – China has seen a huge spike in patent applications, many of which are for pharmaceutical products.

PERTH, Australia – Industry stakeholders in Australia welcomed the Senate passage of the drug and device reforms contained in the Therapeutic Goods Amendment (2016 Measures No. 1) Bill 2016 last week.

HONG KONG – The CFDA has, over the last few years, multiplied supervision of imported pharmaceuticals while speeding up local drug reviews.

More Regulatory Headlines

Cast Your Vote

Should there be restrictions on the use of gene-editing technology?: